Gene: RGPD2
Official Full Name: RANBP2 like and GRIP domain containing 2provided by HGNC
Gene Summary: Predicted to contribute to GTPase activator activity. Predicted to be involved in NLS-bearing protein import into nucleus. Predicted to be part of nuclear pore. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA02019 | RGPD2 Knockout cell line (AC16) | Human | RGPD2 | 1:3-1:4 | negative | Online Inquiry |
| KOA17461 | RGPD2 Knockout cell line (BEAS-2B) | Human | RGPD2 | 1:3~1:4 | negative | Online Inquiry |
| KOA32910 | RGPD2 Knockout cell line (U-2932) | Human | RGPD2 | 1:2-1:4 | negative | Online Inquiry |
| KOA48320 | RGPD2 Knockout cell line (TPC-1) | Human | RGPD2 | 1:5-1:8 | negative | Online Inquiry |
| KOA63720 | RGPD2 Knockout cell line (NCM460) | Human | RGPD2 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.